S.Korean Seegene surges on U.S. FDA's nod for coronavirus test kit

Seegene

22/04/2020 05:08

** Shares of South Korean biotech company Seegene Inc
 096530.KQ  surge as much as 21.2% to 108,000 won 
    ** Seegene received U.S. FDA's Emergency Use Authorization
for its coronavirus test kits on Tuesday
    ** Anticipates FDA's EUA will enable laboratories in the
U.S. to run the Seegene's test immediately for high-volume
testing, the company said in a statement 
    ** U.S. President Donald Trump made a request for devices on
a call with South Korean President Moon Jae-in in March
 urn:newsml:reuters.com:*:nL4N2BI0I9
    ** South Korean test kit maker Osang HealthCare received
FDA's EUA last week for its coronavirus test kits  urn:newsml:reuters.com:*:nL4N2C80BO
    ** The U.S. death toll from COVID-19, the respiratory
disease caused by the virus, topped 45,000 as of Tuesday 
    ** After struggling with the first large outbreak outside of
China, South Korea has largely managed to curb its spread
without lockdowns, helped by a massive testing campaign and
intensive contact tracing
    ** The junior KOSDAQ  .KQ11  was trading down 0.5% as of
0331 GMT 
     

 (Reporting by Heekyong Yang)
 ((Heekyong.Yang@thomsonreuters.com; +82 2 6936 1470;))